86 related articles for article (PubMed ID: 15170152)
21. Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer.
Song SY; Kim WS; Kim K; Jung CW; Im YH; Kim HJ; Kang WK; Lee HG; Kwon OJ; Rhee CH; Park CH; Park K
Jpn J Clin Oncol; 2003 Oct; 33(10):509-13. PubMed ID: 14623918
[TBL] [Abstract][Full Text] [Related]
22. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517
[TBL] [Abstract][Full Text] [Related]
23. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
Br J Cancer; 1997; 76(11):1509-17. PubMed ID: 9400950
[TBL] [Abstract][Full Text] [Related]
25. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
Wozniak AJ; Crowley JJ; Balcerzak SP; Weiss GR; Spiridonidis CH; Baker LH; Albain KS; Kelly K; Taylor SA; Gandara DR; Livingston RB
J Clin Oncol; 1998 Jul; 16(7):2459-65. PubMed ID: 9667264
[TBL] [Abstract][Full Text] [Related]
26. First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine.
Kourousis C; Androulakis N; Kakolyris S; Souglakos J; Maltezakis G; Metaxaris G; Chalkiadakis G; Samonis G; Vlachonikolis J; Georgoulias V
Cancer; 1998 Nov; 83(10):2083-90. PubMed ID: 9827712
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin, ifosfamide, and vinorelbine combination chemotherapy in stage III-IV non-small-cell lung cancer: a phase II study.
Rey F; Astoul P; Marqueste L; Petite JM; Boutin C; Viallat JR
Am J Clin Oncol; 1998 Oct; 21(5):518-22. PubMed ID: 9781613
[TBL] [Abstract][Full Text] [Related]
28. A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer.
Hotta K; Sekine I; Tamura T; Sawada M; Watanabe H; Kusaba H; Akiyama Y; Inoue A; Shimoyama T; Nokihara H; Ueda Y; Yamamoto N; Kunitoh H; Ohe Y; Kodama T; Saijo N
Jpn J Clin Oncol; 2001 Dec; 31(12):596-600. PubMed ID: 11902490
[TBL] [Abstract][Full Text] [Related]
29. Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.
Khuri FR; Rigas JR; Figlin RA; Gralla RJ; Shin DM; Munden R; Fox N; Huyghe MR; Kean Y; Reich SD; Hong WK
J Clin Oncol; 2001 May; 19(10):2626-37. PubMed ID: 11352954
[TBL] [Abstract][Full Text] [Related]
30. Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience.
Mir O; Alexandre J; Ropert S; Montheil V; Martin I; Durand JP; Goldwasser F
Anticancer Drugs; 2009 Feb; 20(2):105-8. PubMed ID: 19209026
[TBL] [Abstract][Full Text] [Related]
31. Second-line chemotherapy with irinotecan and vinorelbine in stage IIIB and IV non-small-cell lung cancer: a phase II study.
González Cao M; Aramendía JM; Salgado E; Aristu J; Martínez Monje R; Algarra SM; Ordoñez JM; Brugarolas A
Am J Clin Oncol; 2002 Oct; 25(5):480-4. PubMed ID: 12393989
[TBL] [Abstract][Full Text] [Related]
32. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
[TBL] [Abstract][Full Text] [Related]
33. Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer.
Chang AY; DeVore R; Johnson D
Semin Oncol; 1996 Apr; 23(2 Suppl 5):19-21. PubMed ID: 8610231
[TBL] [Abstract][Full Text] [Related]
34. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
[TBL] [Abstract][Full Text] [Related]
35. Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancer.
Jassem J; Kosmidis P; Ramlau R; Zarogoulidis K; Novakova L; Breton J; Etienne PL; Seebacher C; Grivaux M; Ojala A; Aubert D; Lefresne F
Ann Oncol; 2003 Nov; 14(11):1634-9. PubMed ID: 14581271
[TBL] [Abstract][Full Text] [Related]
36. Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: a multicenter phase II study.
Makrantonakis P; Ziotopoulos P; Agelidou A; Polyzos A; Ziras A; Chandrinos V; Vossos A; Kalykaki A; Androulakis N; Geroyianni A; Georgoulias V;
Lung Cancer; 2006 Jul; 53(1):85-90. PubMed ID: 16720058
[TBL] [Abstract][Full Text] [Related]
37. Phase I/II trial of paclitaxel and vinorelbine in advanced non-small cell lung cancer.
Grunberg SM; Dugan MC; Greenblatt MS; Ospina DJ; Valentine JW
Cancer Invest; 2005; 23(5):392-8. PubMed ID: 16193638
[TBL] [Abstract][Full Text] [Related]
38. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.
Winton T; Livingston R; Johnson D; Rigas J; Johnston M; Butts C; Cormier Y; Goss G; Inculet R; Vallieres E; Fry W; Bethune D; Ayoub J; Ding K; Seymour L; Graham B; Tsao MS; Gandara D; Kesler K; Demmy T; Shepherd F; ;
N Engl J Med; 2005 Jun; 352(25):2589-97. PubMed ID: 15972865
[TBL] [Abstract][Full Text] [Related]
39. Concurrent chemoradiation with cisplatin and vinorelbine followed by consolidation with oral vinorelbine in locally advanced non-small cell lung cancer (NSCLC): the phase II CONCAVE study.
Hughes BG; Ahern E; Lehman M; Pratt G; Dauth M; Pritchard W; Wockner L; Horwood K
Asia Pac J Clin Oncol; 2017 Jun; 13(3):137-144. PubMed ID: 28181415
[TBL] [Abstract][Full Text] [Related]
40. Is cisplatin required for the treatment of non-small-cell lung cancer? Experience and preliminary results of a phase I/II trial with topotecan and vinorelbine.
Stupp R; Bodmer A; Duvoisin B; Bauer J; Perey L; Bakr M; Ketterer N; Leyvraz S
Oncology; 2001; 61 Suppl 1():35-41. PubMed ID: 11598413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
